期刊文献+

鼻用黄芩苷磷脂复合物原位凝胶对鼻黏膜的毒性研究 被引量:7

Toxicity evaluation of Baicalin-phospholipid nasal in situ gel on nasal mucosa
原文传递
导出
摘要 目的评价黄芩苷磷脂复合物原位凝胶经鼻给药的鼻黏膜毒性。方法在体蟾蜍药物对纤毛运动的影响,用溶血实验考察药物对生物膜的作用。结果黄芩苷磷脂复合物原位凝胶对蟾蜍鼻纤毛的运动几乎无影响,纤毛运动时间相对百分率约90.1%,并不产生溶血反应。结论黄芩苷磷脂复合物原位凝胶鼻腔给药无明显毒性,经鼻给药的开发是可行的。 OBJECTIVE To investigate the toxicity of Baicalin-phospholipid nasal in situ gel(BPG).METHODS The effects of BPG on nasal cilia movement were tested with palate of isolated toad,and the effects on biomembrane were observed by hemolytic tests.RESULTS There were no significant effects of BPG on the nasal ciliarymovement,the relative percentage of the lasting time of ciliary movement was 90.1% approximately.And BPG showed no hemolytic effect.CONCLUSION The BPG has no significant toxicity on nasal mucosa and can be used as a drug for the intranasal administration.
出处 《华西药学杂志》 CAS CSCD 北大核心 2011年第5期469-470,共2页 West China Journal of Pharmaceutical Sciences
关键词 黄芩苷磷脂复合物 鼻用原位凝胶 鼻黏膜 鼻腔给药 黏膜毒性 Baicalin-phospholipid Nasal in situ gel Nasal mucosa Intranasal administration Mucosal toxicity
  • 相关文献

参考文献3

二级参考文献30

  • 1蒋新国,崔景斌,方晓玲,韦阳,奚念朱.药物的鼻粘膜纤毛毒性及评价方法[J].药学学报,1995,30(11):848-853. 被引量:86
  • 2陆翔 蒋新国 等.促进剂对大鼠鼻粘膜药物吸收的影响[J].上海医科大学学报,1996,23:49-49.
  • 3[1]Shanmuganathan K,Koudriakova T,Nampalli S,et al.Enhanced brain delivery of anti-HIV nucleoside 2-F-ara-ddI by xanthine oxidase mediated biotransformation[J].J Med Chem,1994,37(6):821.
  • 4[2]Yoshikawa T,Sakaeda T,Sugawara T,et al.A novel chemical delivery system for brain targeting[J].Adv Drug Del Rev,1999,36(2-3):255.
  • 5[3]Tsuji A,Tamai I.Carrier-mediated or specialized transport of drugs across the blood-brain barrier[J].Adv Drug Del Rev,1999;36(2-3):277.
  • 6[4]Kang YS,Pardridge WM.Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin[J].Pharm Res,1994,11(9):1257.
  • 7[5]Podulso JF,Curran GL,Gill JS.Putrescine-modified nerve growth factor:bioactivity,plasma pharmacokinetics,blood-brain/nerve barrier permeability,and nervous system biodistribution[J].J Neurochem,1998,71(4):1651.
  • 8[6]Wu D,Pardridge WM.CNS pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analouge coupled to a blood-brain barrier delivery system[J].J Pharmacol Exp Ther,1996,279(1):77.
  • 9[7]Pardridge WM,Wu D,Sakane T.Combined use of carboxyl-directed protein pegylation and vector-mediated blood -brain barrier durg delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration[J].Pharm Res,1998,15(4):576.
  • 10[8]Kang YS,Saito Y,Pardridge WM.Pharmacokinetics of [3H]-biotin bound to different avidin analogues[J].J Drug Target,1995,3(2):159.

共引文献122

同被引文献101

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部